# Fibrinogen as a Surrogate for Global Haemostasis in Plasma Exchange

> **NCT02095821** · — · TERMINATED · sponsor: **Hannover Medical School** · enrollment: 2 (actual)

## Conditions studied

- Clotting Disorder Due to Plasma Exchange Therapy
- Humoral Rejection After Kidney Transplantation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02095821
- **Lead sponsor:** Hannover Medical School
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02
- **Primary completion:** 2019-10
- **Final completion:** 2019-10
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Study was stopped due to recruitment failure
- **Last updated:** 2020-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02095821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02095821, "Fibrinogen as a Surrogate for Global Haemostasis in Plasma Exchange". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02095821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*